These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 26518336

  • 1. Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.
    Caviness JN, Utianski RL, Hentz JG, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH.
    Eur J Neurol; 2016 Feb; 23(2):387-92. PubMed ID: 26518336
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.
    Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, Powell JJ, Adler CH.
    J Parkinsons Dis; 2015 Feb; 5(1):117-24. PubMed ID: 25420672
    [Abstract] [Full Text] [Related]

  • 3. Association Between Pathology and Electroencephalographic Activity in Parkinson's Disease.
    Caviness JN, Beach TG, Hentz JG, Shill HA, Driver-Dunckley ED, Adler CH.
    Clin EEG Neurosci; 2018 Sep; 49(5):321-327. PubMed ID: 29161906
    [Abstract] [Full Text] [Related]

  • 4. Quantitative EEG as a predictive biomarker for Parkinson disease dementia.
    Klassen BT, Hentz JG, Shill HA, Driver-Dunckley E, Evidente VG, Sabbagh MN, Adler CH, Caviness JN.
    Neurology; 2011 Jul 12; 77(2):118-24. PubMed ID: 21633128
    [Abstract] [Full Text] [Related]

  • 5. Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders.
    Caviness JN, Adler CH, Hentz JG, Shill HA, Evidente VG, Driver-Dunckley ED, Sabbagh MN, Sue L, Beach TG.
    Clin Neurophysiol; 2011 Dec 12; 122(12):2426-32. PubMed ID: 21616709
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contribution of Quantitative EEG to the Diagnosis of Early Cognitive Impairment in Patients With Idiopathic Parkinson's Disease.
    Guner D, Tiftikcioglu BI, Tuncay N, Zorlu Y.
    Clin EEG Neurosci; 2017 Sep 12; 48(5):348-354. PubMed ID: 27491643
    [Abstract] [Full Text] [Related]

  • 8. Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease.
    Chaturvedi M, Bogaarts JG, Kozak Cozac VV, Hatz F, Gschwandtner U, Meyer A, Fuhr P, Roth V.
    Clin Neurophysiol; 2019 Oct 12; 130(10):1937-1944. PubMed ID: 31445388
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.
    Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Intorcia A, Filon J, Scott S, Garcia A, Hoffman B, Belden CM, Davis KJ, Sabbagh MN, Arizona Parkinson's Disease Consortium.
    J Parkinsons Dis; 2016 Oct 12; 6(1):153-63. PubMed ID: 26756744
    [Abstract] [Full Text] [Related]

  • 11. Advanced qEEG analyses discriminate between dementia subtypes.
    Burelo M, Bray J, Gulka O, Firbank M, Taylor JP, Platt B.
    J Neurosci Methods; 2024 Sep 12; 409():110195. PubMed ID: 38889843
    [Abstract] [Full Text] [Related]

  • 12. Dementia, mild cognitive impairment and quantitative EEG in patients with Parkinson's disease.
    Fonseca LC, Tedrus GM, Letro GH, Bossoni AS.
    Clin EEG Neurosci; 2009 Jul 12; 40(3):168-72. PubMed ID: 19715179
    [Abstract] [Full Text] [Related]

  • 13. Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson's Disease.
    Novak K, Chase BA, Narayanan J, Indic P, Markopoulou K.
    Front Aging Neurosci; 2021 Jul 12; 13():804991. PubMed ID: 35046794
    [Abstract] [Full Text] [Related]

  • 14. Utility of quantitative EEG in early Lewy body disease.
    Massa F, Meli R, Grazzini M, Famà F, De Carli F, Filippi L, Arnaldi D, Pardini M, Morbelli S, Nobili F.
    Parkinsonism Relat Disord; 2020 Jun 12; 75():70-75. PubMed ID: 32480310
    [Abstract] [Full Text] [Related]

  • 15. Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease.
    Caviness JN, Lue LF, Hentz JG, Schmitz CT, Adler CH, Shill HA, Sabbagh MN, Beach TG, Walker DG.
    Mov Disord; 2016 Jul 12; 31(7):1012-9. PubMed ID: 27062301
    [Abstract] [Full Text] [Related]

  • 16. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG, White CL, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH, Arizona Parkinson's Disease Consortium.
    Acta Neuropathol; 2009 Feb 12; 117(2):169-74. PubMed ID: 18982334
    [Abstract] [Full Text] [Related]

  • 17. Integrative Frequency Power of EEG Correlates with Progression of Mild Cognitive Impairment to Dementia in Parkinson's Disease.
    Gu Y, Chen J, Lu Y, Pan S.
    Clin EEG Neurosci; 2016 Apr 12; 47(2):113-7. PubMed ID: 25519446
    [Abstract] [Full Text] [Related]

  • 18. Electroencephalogram slowing predicts neurodegeneration in rapid eye movement sleep behavior disorder.
    Rodrigues Brazète J, Gagnon JF, Postuma RB, Bertrand JA, Petit D, Montplaisir J.
    Neurobiol Aging; 2016 Jan 12; 37():74-81. PubMed ID: 26545633
    [Abstract] [Full Text] [Related]

  • 19. Presymptomatic Parkinson's disease: the Arizona experience.
    Caviness JN.
    Parkinsonism Relat Disord; 2012 Jan 12; 18 Suppl 1():S203-6. PubMed ID: 22166435
    [Abstract] [Full Text] [Related]

  • 20. Resting state oscillatory brain dynamics in Parkinson's disease: an MEG study.
    Bosboom JL, Stoffers D, Stam CJ, van Dijk BW, Verbunt J, Berendse HW, Wolters ECh.
    Clin Neurophysiol; 2006 Nov 12; 117(11):2521-31. PubMed ID: 16997626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.